|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 6275 for Fas

<< First    < Previous  |  Next >    Last >>
0.019s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
GXD Expression
GXD Expression
     
Probe: MGI:6172684
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:6190249
Age: postnatal day 4
Specimen Label: Table S2 - P4 - Fas
Detected: false
Specimen Num: 5
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6172684
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:6190249
Age: postnatal day 14
Specimen Label: Table S2 - P14 - Fas
Detected: false
Specimen Num: 6
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6172684
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:6190249
Age: postnatal day 28
Specimen Label: Table S2 - P28 - Fas
Detected: false
Specimen Num: 7
•
•
•
•
•
Publication
7528774 | J:22200
First Author: Chu JL
Year: 1995
Journal: J Exp Med
Title: Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome.
Volume: 181
Issue: 1
Pages: 393-8
•
•
•
•
•
Publication
11067900 | J:119582
First Author: Wahlsten JL
Year: 2000
Journal: J Immunol
Title: Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
Volume: 165
Issue: 10
Pages: 5480-6
•
•
•
•
•
Publication
18275831 | J:132217
First Author: Hutcheson J
Year: 2008
Journal: Immunity
Title: Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity.
Volume: 28
Issue: 2
Pages: 206-17
•
•
•
•
•
Publication
18275832 | J:132216
First Author: Weant AE
Year: 2008
Journal: Immunity
Title: Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction.
Volume: 28
Issue: 2
Pages: 218-30
•
•
•
•
•
Publication
18275830 | J:132218
First Author: Hughes PD
Year: 2008
Journal: Immunity
Title: Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity.
Volume: 28
Issue: 2
Pages: 197-205
•
•
•
•
•
Publication
30429213 | J:271164
First Author: Xiao W
Year: 2019
Journal: Mol Cancer Res
Title: Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy.
Volume: 17
Issue: 2
Pages: 420-430
•
•
•
•
•
Publication
10209045 | J:54480
First Author: Hill LL
Year: 1999
Journal: J Exp Med
Title: A critical role for Fas ligand in the active suppression of systemic immune responses by ultraviolet radiation.
Volume: 189
Issue: 8
Pages: 1285-94
•
•
•
•
•
Publication
8757318 | J:34896
First Author: Yasutomo K
Year: 1996
Journal: J Immunol
Title: Fas system-mediated apoptosis suppresses lymphopoiesis.
Volume: 157
Issue: 5
Pages: 1981-6
•
•
•
•
•
Publication
10679090 | J:127009
First Author: Su X
Year: 2000
Journal: J Immunol
Title: Significant role for Fas in the pathogenesis of autoimmune diabetes.
Volume: 164
Issue: 5
Pages: 2523-32
•
•
•
•
•
Publication
21479271 | J:171440
First Author: Gregory MS
Year: 2011
Journal: PLoS One
Title: Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death.
Volume: 6
Issue: 3
Pages: e17659
•
•
•
•
•
Publication
9574511 | J:47570
First Author: Huang FP
Year: 1998
Journal: J Immunol
Title: Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses, and enhanced nitric oxide production.
Volume: 160
Issue: 9
Pages: 4143-7
•
•
•
•
•
Publication
14985447 | J:97007
First Author: Hayley S
Year: 2004
Journal: J Neurosci
Title: Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Volume: 24
Issue: 8
Pages: 2045-53
•
•
•
•
•
Publication
19755672 | J:159568
First Author: Choi D
Year: 2009
Journal: Am J Physiol Endocrinol Metab
Title: Deletion of Fas in the pancreatic beta-cells leads to enhanced insulin secretion.
Volume: 297
Issue: 6
Pages: E1304-12
•
•
•
•
•
Publication
19794494 | J:153501
First Author: O' Reilly LA
Year: 2009
Journal: Nature
Title: Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
Volume: 461
Issue: 7264
Pages: 659-63
•
•
•
•
•
Publication
15569774 | J:94796
First Author: Caucheteux SM
Year: 2005
Journal: Int Immunol
Title: Pregnancy-induced alterations of B cell maturation and survival are differentially affected by Fas and Bcl-2, independently of BcR expression.
Volume: 17
Issue: 1
Pages: 55-63
•
•
•
•
•
Publication
11714837 | J:72817
First Author: Kennedy NJ
Year: 2001
Journal: J Immunol
Title: Liver damage by infiltrating CD8+ T cells is Fas dependent.
Volume: 167
Issue: 11
Pages: 6654-62
•
•
•
•
•
Publication
21061436 | J:165842
First Author: Fortner KA
Year: 2010
Journal: Eur J Immunol
Title: Apoptosis regulators Fas and Bim synergistically control T-lymphocyte homeostatic proliferation.
Volume: 40
Issue: 11
Pages: 3043-53
•
•
•
•
•
Publication
11441070 | J:109872
First Author: Medana I
Year: 2001
Journal: J Immunol
Title: Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity.
Volume: 167
Issue: 2
Pages: 674-81
•
•
•
•
•
Publication
23269409 | J:195933
First Author: Feng ZC
Year: 2013
Journal: Am J Physiol Endocrinol Metab
Title: Downregulation of Fas activity rescues early onset of diabetes in c-Kit(Wv/+) mice.
Volume: 304
Issue: 6
Pages: E557-65
•
•
•
•
•
Publication
26444718 | J:231062
First Author: Rogge M
Year: 2015
Journal: Invest Ophthalmol Vis Sci
Title: Therapeutic Use of Soluble Fas Ligand Ameliorates Acute and Recurrent Herpetic Stromal Keratitis in Mice.
Volume: 56
Issue: 11
Pages: 6377-86
•
•
•
•
•
Publication
11780924 | J:105850
First Author: Yin Y
Year: 2002
Journal: J Androl
Title: P53 and Fas are sequential mechanisms of testicular germ cell apoptosis.
Volume: 23
Issue: 1
Pages: 64-70
•
•
•
•
•
Publication
9915863 | J:115231
First Author: Mittelstadt PR
Year: 1999
Journal: J Biol Chem
Title: Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells.
Volume: 274
Issue: 5
Pages: 3222-7
•
•
•
•
•
Publication
16527894 | J:135681
First Author: Rubiolo C
Year: 2006
Journal: Blood
Title: A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation.
Volume: 108
Issue: 1
Pages: 152-9
•
•
•
•
•
Publication
15148335 | J:114948
First Author: Hao Z
Year: 2004
Journal: J Exp Med
Title: T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis.
Volume: 199
Issue: 10
Pages: 1355-65
•
•
•
•
•
Publication
7529644 | J:20345
First Author: Matsuyama T
Year: 1994
Journal: Brain Res
Title: Fas antigen mRNA induction in postischemic murine brain.
Volume: 657
Issue: 1-2
Pages: 342-6
•
•
•
•
•
Publication
10453074 | J:114219
First Author: Suzuki A
Year: 1999
Journal: Cell Death Differ
Title: Another cell death induction system: TNF-alpha acts as a ligand for Fas in vaginal cells.
Volume: 6
Issue: 7
Pages: 638-43
•
•
•
•
•
Publication
23220580 | J:199970
First Author: Takahashi S
Year: 2013
Journal: Int Immunol
Title: Fas deficiency in mice with the Balb/c background induces blepharitis with allergic inflammation and hyper-IgE production in conjunction with severe autoimmune disease.
Volume: 25
Issue: 5
Pages: 287-93
•
•
•
•
•
Protein
Q78DY9
Organism: Mus musculus/domesticus
Length: 56  
Fragment?: true
•
•
•
•
•
Publication
30383451 | J:287999
First Author: Lazić Mosler E
Year: 2019
Journal: FASEB J
Title: Fas receptor induces apoptosis of synovial bone and cartilage progenitor populations and promotes bone loss in antigen-induced arthritis.
Volume: 33
Issue: 3
Pages: 3330-3342
•
•
•
•
•
Publication
9802983 | J:52778
First Author: Owen-Schaub LB
Year: 1998
Journal: J Exp Med
Title: Fas and Fas ligand interactions suppress melanoma lung metastasis.
Volume: 188
Issue: 9
Pages: 1717-23
•
•
•
•
•
Publication
7536012 | J:22217
First Author: Singer GG
Year: 1994
Journal: Curr Opin Immunol
Title: Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model.
Volume: 6
Issue: 6
Pages: 913-20
•
•
•
•
•
Publication
17889725 | J:126346
First Author: Pearl-Yafe M
Year: 2007
Journal: Exp Hematol
Title: Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis.
Volume: 35
Issue: 10
Pages: 1601-12
•
•
•
•
•
Publication
14978078 | J:88238
First Author: Kong PL
Year: 2004
Journal: J Immunol
Title: The centromeric region of chromosome 7 from MRL mice (Lmb3) is an epistatic modifier of Fas for autoimmune disease expression.
Volume: 172
Issue: 5
Pages: 2785-94
•
•
•
•
•
Publication
15980239 | J:136745
First Author: Engelbert M
Year: 2005
Journal: Invest Ophthalmol Vis Sci
Title: Fas ligand but not complement is critical for control of experimental Staphylococcus aureus Endophthalmitis.
Volume: 46
Issue: 7
Pages: 2479-86
•
•
•
•
•
Publication
10527913 | J:59708
First Author: Kamath AB
Year: 1999
Journal: Toxicol Appl Pharmacol
Title: Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity.
Volume: 160
Issue: 2
Pages: 141-55
•
•
•
•
•
Publication
7520535 | J:146737
First Author: Lowin B
Year: 1994
Journal: Nature
Title: Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways.
Volume: 370
Issue: 6491
Pages: 650-2
•
•
•
•
•
Publication
7511063 | J:17445
First Author: Takahashi T
Year: 1994
Journal: Cell
Title: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
Volume: 76
Issue: 6
Pages: 969-76
•
•
•
•
•
Publication
16365167 | J:104536
First Author: Piazzolla D
Year: 2005
Journal: J Cell Biol
Title: Raf-1 sets the threshold of Fas sensitivity by modulating Rok-alpha signaling.
Volume: 171
Issue: 6
Pages: 1013-22
•
•
•
•
•
Publication
22573809 | J:188880
First Author: Cai Z
Year: 2012
Journal: J Immunol
Title: Activated T cell exosomes promote tumor invasion via Fas signaling pathway.
Volume: 188
Issue: 12
Pages: 5954-61
•
•
•
•
•
Publication
16764695 | J:129290
First Author: Mastache EF
Year: 2006
Journal: Scand J Immunol
Title: Somatic hypermutation of Ig genes is affected differently by failures in apoptosis caused by disruption of Fas (lpr mutation) or by overexpression of Bcl-2.
Volume: 63
Issue: 6
Pages: 420-9
•
•
•
•
•
Publication
9862686 | J:333626
First Author: Iwakura Y
Year: 1998
Journal: J Immunol
Title: The development of autoimmune inflammatory arthropathy in mice transgenic for the human T cell leukemia virus type-1 env-pX region is not dependent on H-2 haplotypes and modified by the expression levels of Fas antigen.
Volume: 161
Issue: 12
Pages: 6592-8
•
•
•
•
•
Publication
19955656 | J:156776
First Author: Wueest S
Year: 2010
Journal: J Clin Invest
Title: Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice.
Volume: 120
Issue: 1
Pages: 191-202
•
•
•
•
•
Publication
12672068 | J:82862
First Author: Yajima K
Year: 2003
Journal: Eur J Immunol
Title: FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
Volume: 33
Issue: 4
Pages: 1020-9
•
•
•
•
•
Publication
11782013 | J:73933
First Author: Fukuyama H
Year: 2002
Journal: Eur J Immunol
Title: Requirement of Fas expression in B cells for tolerance induction.
Volume: 32
Issue: 1
Pages: 223-30
•
•
•
•
•
Publication
21076068 | J:167466
First Author: Kinjyo I
Year: 2010
Journal: J Immunol
Title: Cutting edge: Lymphoproliferation caused by Fas deficiency is dependent on the transcription factor eomesodermin.
Volume: 185
Issue: 12
Pages: 7151-5
•
•
•
•
•
Publication
30610162 | J:270106
First Author: Jangalwe S
Year: 2019
Journal: J Immunol
Title: Cutting Edge: Early Attrition of Memory T Cells during Inflammation and Costimulation Blockade Is Regulated Concurrently by Proapoptotic Proteins Fas and Bim.
Volume: 202
Issue: 3
Pages: 647-651
•
•
•
•
•
Publication
18835195 | J:141441
First Author: Hao Z
Year: 2008
Journal: Immunity
Title: Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis.
Volume: 29
Issue: 4
Pages: 615-27
•
•
•
•
•
Publication
23341634 | J:193821
First Author: Listopad JJ
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Fas expression by tumor stroma is required for cancer eradication.
Volume: 110
Issue: 6
Pages: 2276-81
•
•
•
•
•
Publication
34223817 | J:310621
   
First Author: Jeong D
Year: 2021
Journal: Elife
Title: Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2.
Volume: 10
•
•
•
•
•
Publication
14525977 | J:87085
First Author: Xiao S
Year: 2003
Journal: J Biol Chem
Title: Combining Fas mutation with interleukin-2 deficiency prevents Colitis and Lupus: implicating interleukin-2 for auto-reactive T cell expansion and Fas ligand for colon epithelial cell death.
Volume: 278
Issue: 52
Pages: 52730-8
•
•
•
•
•
Publication
10791994 | J:62111
First Author: Nelson DP
Year: 2000
Journal: J Clin Invest
Title: Proinflammatory consequences of transgenic fas ligand expression in the heart.
Volume: 105
Issue: 9
Pages: 1199-208
•
•
•
•
•
Publication
9639581 | J:48585
 
First Author: Pang H
Year: 1998
Journal: Biochem J
Title: Sp3 regulates fas expression in lung epithelial cells.
Volume: 333 ( Pt 1)
Pages: 209-13
•
•
•
•
•
Publication
15086909 | J:102219
First Author: Morito N
Year: 2004
Journal: Kidney Int
Title: Nrf2 deficiency improves autoimmune nephritis caused by the fas mutation lpr.
Volume: 65
Issue: 5
Pages: 1703-13
•
•
•
•
•
Publication
9743374 | J:112246
First Author: Rafi AQ
Year: 1998
Journal: J Immunol
Title: Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome.
Volume: 161
Issue: 6
Pages: 3077-86
•
•
•
•
•
Publication
10712254 | J:60879
First Author: Pinkoski MJ
Year: 2000
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Fas and Fas ligand in gut and liver.
Volume: 278
Issue: 3
Pages: G354-66
•
•
•
•
•
Publication
16585548 | J:131190
First Author: Nowak M
Year: 2006
Journal: J Immunol
Title: Oral nickel tolerance: Fas ligand-expressing invariant NK T cells promote tolerance induction by eliciting apoptotic death of antigen-carrying, effete B cells.
Volume: 176
Issue: 8
Pages: 4581-9
•
•
•
•
•
Publication
19001138 | J:141398
First Author: Gupta VA
Year: 2008
Journal: J Exp Med
Title: B cells drive lymphocyte activation and expansion in mice with the CD45 wedge mutation and Fas deficiency.
Volume: 205
Issue: 12
Pages: 2755-61
•
•
•
•
•
Publication
8738468 | J:33149
First Author: Cullen CM
Year: 1995
Journal: Pathobiology
Title: A fas antigen receptor mutation allows development of toxic shock syndrome toxin-1-induced lethal shock in V beta 8.2 T-cell receptor transgenic mice.
Volume: 63
Issue: 6
Pages: 293-304
•
•
•
•
•
Publication
23943615 | J:203852
First Author: Qian C
Year: 2013
Journal: J Biol Chem
Title: Fas signal promotes the immunosuppressive function of regulatory dendritic cells via the ERK/β-catenin pathway.
Volume: 288
Issue: 39
Pages: 27825-35
•
•
•
•
•
Publication
15039234 | J:89131
First Author: Hiatt K
Year: 2004
Journal: Am J Pathol
Title: Loss of the nf1 tumor suppressor gene decreases fas antigen expression in myeloid cells.
Volume: 164
Issue: 4
Pages: 1471-9
•
•
•
•
•
Publication
16574667 | J:109099
First Author: McKenzie MD
Year: 2006
Journal: Int Immunol
Title: Perforin and Fas induced by IFNgamma and TNFalpha mediate beta cell death by OT-I CTL.
Volume: 18
Issue: 6
Pages: 837-46
•
•
•
•
•
Publication
16301623 | J:122147
First Author: Park H
Year: 2005
Journal: J Immunol
Title: Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis.
Volume: 175
Issue: 11
Pages: 7193-201
•
•
•
•
•
Publication
8579749 | J:29893
First Author: Lynch DH
Year: 1995
Journal: Immunol Today
Title: Fas and FasL in the homeostatic regulation of immune responses.
Volume: 16
Issue: 12
Pages: 569-74
•
•
•
•
•
Publication
17299038 | J:125892
First Author: Schumann DM
Year: 2007
Journal: Proc Natl Acad Sci U S A
Title: The Fas pathway is involved in pancreatic beta cell secretory function.
Volume: 104
Issue: 8
Pages: 2861-6
•
•
•
•
•
Publication
12761576 | J:115715
First Author: Sakata S
Year: 2003
Journal: Cell Death Differ
Title: Involvement of death receptor Fas in germ cell degeneration in gonads of Kit-deficient Wv/Wv mutant mice.
Volume: 10
Issue: 6
Pages: 676-86
•
•
•
•
•
Publication
34536556 | J:311808
 
First Author: Yang F
Year: 2021
Journal: Cancer Lett
Title: Fas signaling in adipocytes promotes low-grade inflammation and lung metastasis of colorectal cancer through interaction with Bmx.
Volume: 522
Pages: 93-104
•
•
•
•
•
Publication
20881190 | J:165185
First Author: Xie Y
Year: 2010
Journal: J Immunol
Title: Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
Volume: 185
Issue: 9
Pages: 5268-78
•
•
•
•
•
Publication
18219273 | J:131818
First Author: Krum SA
Year: 2008
Journal: EMBO J
Title: Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival.
Volume: 27
Issue: 3
Pages: 535-45
•
•
•
•
•
Publication
11567045 | J:124252
First Author: Morishima Y
Year: 2001
Journal: J Neurosci
Title: Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand.
Volume: 21
Issue: 19
Pages: 7551-60
•
•
•
•
•
Publication
25744024 | J:258989
First Author: Wang L
Year: 2015
Journal: Cell Death Differ
Title: Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.
Volume: 22
Issue: 10
Pages: 1654-64
•
•
•
•
•
Publication
10497129 | J:57906
First Author: Di Cristofano A
Year: 1999
Journal: Science
Title: Impaired Fas response and autoimmunity in Pten+/- mice.
Volume: 285
Issue: 5436
Pages: 2122-5
•
•
•
•
•
Publication
23144495 | J:190865
First Author: Bossaller L
Year: 2012
Journal: J Immunol
Title: Cutting edge: FAS (CD95) mediates noncanonical IL-1β and IL-18 maturation via caspase-8 in an RIP3-independent manner.
Volume: 189
Issue: 12
Pages: 5508-12
•
•
•
•
•
Publication
8598462 | J:31074
First Author: Tucek-Szabo CL
Year: 1996
Journal: J Immunol
Title: Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor.
Volume: 156
Issue: 1
Pages: 192-200
•
•
•
•
•
Publication
29436413 | J:259415
First Author: Kotov DI
Year: 2018
Journal: J Immunol
Title: Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential.
Volume: 200
Issue: 6
Pages: 2004-2012
•
•
•
•
•
Publication
9380404 | J:43292
First Author: Reinke V
Year: 1997
Journal: Oncogene
Title: The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo.
Volume: 15
Issue: 13
Pages: 1527-34
•
•
•
•
•
Publication
29908447 | J:318467
 
First Author: Adkins LJ
Year: 2018
Journal: Virology
Title: Fas activity mediates airway inflammation during mouse adenovirus type 1 respiratory infection.
Volume: 521
Pages: 129-137
•
•
•
•
•
Publication
21550016 | J:173162
First Author: de Claro RA
Year: 2011
Journal: Am J Pathol
Title: Hematopoietic Fas deficiency does not affect experimental atherosclerotic lesion formation despite inducing a proatherogenic state.
Volume: 178
Issue: 6
Pages: 2931-7
•
•
•
•
•
Publication
16936188 | J:116592
First Author: Dudek NL
Year: 2006
Journal: Diabetes
Title: Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways.
Volume: 55
Issue: 9
Pages: 2412-8
•
•
•
•
•
Publication
8757305 | J:34897
First Author: Foote LC
Year: 1996
Journal: J Immunol
Title: Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells.
Volume: 157
Issue: 5
Pages: 1878-85
•
•
•
•
•
Publication
11741599 | J:73329
First Author: Wenzel J
Year: 2001
Journal: FEBS Lett
Title: Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor.
Volume: 509
Issue: 2
Pages: 255-62
•
•
•
•
•
Publication
8990386 | J:37400
First Author: Selvaggi G
Year: 1996
Journal: Transplantation
Title: The role of the perforin and Fas pathways of cytotoxicity in skin graft rejection.
Volume: 62
Issue: 12
Pages: 1912-5
•
•
•
•
•
Publication
8750874 | J:29757
First Author: Matsuyama T
Year: 1995
Journal: Brain Res Mol Brain Res
Title: Localization of Fas antigen mRNA induced in postischemic murine forebrain by in situ hybridization.
Volume: 34
Issue: 1
Pages: 166-72
•
•
•
•
•
Publication
7595210 | J:29455
First Author: Hughes DP
Year: 1995
Journal: J Exp Med
Title: A naturally occurring soluble isoform of murine Fas generated by alternative splicing.
Volume: 182
Issue: 5
Pages: 1395-401
•
•
•
•
•
Publication
7524484 | J:20568
First Author: Guo MW
Year: 1994
Journal: Biochem Biophys Res Commun
Title: Identification of Fas antigen associated with apoptotic cell death in murine ovary.
Volume: 203
Issue: 3
Pages: 1438-46
•
•
•
•
•
Publication
9466307 | J:45034
First Author: Nishimura-Morita Y
Year: 1997
Journal: Int Immunol
Title: Amelioration of systemic autoimmune disease by the stimulation of apoptosis-promoting receptor Fas with anti-Fas mAb.
Volume: 9
Issue: 12
Pages: 1793-9
•
•
•
•
•
Publication
16177078 | J:118982
First Author: Fortner KA
Year: 2005
Journal: J Immunol
Title: The death receptor Fas (CD95/APO-1) mediates the deletion of T lymphocytes undergoing homeostatic proliferation.
Volume: 175
Issue: 7
Pages: 4374-82
•
•
•
•
•
Publication
12488132 | J:81306
First Author: Denning TL
Year: 2002
Journal: Free Radic Biol Med
Title: Oxidative stress induces the expression of Fas and Fas ligand and apoptosis in murine intestinal epithelial cells.
Volume: 33
Issue: 12
Pages: 1641-50
•
•
•
•
•
Publication
21266499 | J:168554
First Author: Fortner KA
Year: 2011
Journal: Int Immunol
Title: Fas (CD95/APO-1) limits the expansion of T lymphocytes in an environment of limited T-cell antigen receptor/MHC contacts.
Volume: 23
Issue: 2
Pages: 75-88
•
•
•
•
•
Publication
17509906 | J:123556
First Author: Stranges PB
Year: 2007
Journal: Immunity
Title: Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity.
Volume: 26
Issue: 5
Pages: 629-41
•
•
•
•
•
Publication
9769336 | J:115242
First Author: Fleck M
Year: 1998
Journal: J Clin Invest
Title: Apoptosis mediated by Fas but not tumor necrosis factor receptor 1 prevents chronic disease in mice infected with murine cytomegalovirus.
Volume: 102
Issue: 7
Pages: 1431-43
•
•
•
•
•
Publication
11884544 | J:126472
First Author: Licon Luna RM
Year: 2002
Journal: J Virol
Title: Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice.
Volume: 76
Issue: 7
Pages: 3202-11
•
•
•
•
•
Publication
8663376 | J:34155
First Author: Takahashi T
Year: 1996
Journal: J Biol Chem
Title: Swapping between Fas and granulocyte colony-stimulating factor receptor.
Volume: 271
Issue: 29
Pages: 17555-60
•
•
•
•
•
Publication
12840807 | J:84473
First Author: Komatsu K
Year: 2003
Journal: Mol Reprod Dev
Title: Soluble Fas (FasB) regulates luteal cell apoptosis during luteolysis in murine ovaries.
Volume: 65
Issue: 4
Pages: 345-52
•
•
•
•
•
Publication
7536770 | J:24963
First Author: Nishimura Y
Year: 1995
Journal: J Immunol
Title: Expression and function of mouse Fas antigen on immature and mature T cells.
Volume: 154
Issue: 9
Pages: 4395-403
•
•
•
•
•
Publication
8605699 | J:32458
First Author: Meryhew NL
Year: 1996
Journal: Clin Immunol Immunopathol
Title: Abnormal complement-mediated immune clearance in MRL-lpr/+ heterozygote mice: dose-dependent effect of the Fas antigen mutation.
Volume: 78
Issue: 3
Pages: 236-44
•
•
•
•
•
Publication
10497009 | J:57833
First Author: Choi Y
Year: 1999
Journal: Clin Immunol
Title: Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Volume: 93
Issue: 1
Pages: 34-45
•
•
•
•
•
Publication
16301997 | J:107261
First Author: Villa-Morales M
Year: 2006
Journal: Oncogene
Title: Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to gamma-radiation-induced thymic lymphoma.
Volume: 25
Issue: 14
Pages: 2022-9
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom